(ERYP)$4.40 RUNNINGGGGGGG...Market cap $115 ma low priced under radar Cancer Drug company which could have 2 HUGE cancer drug approved by next year ..a potential $50 stock trading at laughable 4 bucks
“We are encouraged by the interactive dialogue with the agency, and grateful for the feedback and guidance we received on a potential path to approval,” said Gil Beyen, CEO of ERYTECH. “This is an important milestone for ERYTECH as it advances our lead product candidate eryaspase as an alternative treatment for ALL patients with hypersensitivity to PEG-asparaginase, while our Phase 3 trial in second line pancreatic cancer is nearing completion. If all goes well, we could be in a position to make this product candidate available to ALL and pancreatic cancer patients in the course of next year.”
